Asensus Surgical to Participate in the H. C. Wainwright Global Investment Conference

Rhea-AI Summary

Asensus Surgical, Inc. (NYSE American: ASXC) will participate in the H. C. Wainwright 24th Annual Global Investment Conference in New York City on September 12, 2022, at 9:30 AM ET. CEO Anthony Fernando and CFO Shameze Rampertab will host a fireside chat, accessible via a live webcast on the company's investor relations page. The conference aims to enhance investor engagement and share insights about Asensus's innovative Performance-Guided Surgery™ and Digital Laparoscopy technologies. A replay of the session will be available for 90 days on their website.

RESEARCH TRIANGLE PARK, N.C., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the H. C. Wainwright 24th Annual Global Investment Conference in New York City, New York. The Company’s fireside chat will take place on Monday, September 12, 2022 at 9:30 AM Eastern Time.

The H. C. Wainwright Global Investment Conference webcast will be available online on the investor relations page of the Company’s website at https://ir.asensus.com/events-and-presentations. Replay of the webcast will be archived on the website for approximately 90 days.

About Asensus Surgical, Inc.

Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™ by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance® Surgical System powered by the Intelligent Surgical Unit™ (ISU™) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: www.senhance.com/indications. For more information, visit www.asensus.com.

Follow Asensus

• Email Alerts: https://ir.asensus.com/email-alerts
• LinkedIn: https://www.linkedin.com/company/asensus-surgical-inc
• Twitter: https://twitter.com/AsensusSurgical
• YouTube: https://www.youtube.com/c/transenterix
• Vimeo: https://vimeo.com/asxc
  

INVESTOR CONTACT:
Mark Klausner or Mike Vallie, 443-213-0499
invest@asensus.com 
or
MEDIA CONTACT:
Lauren Stredler, 847-271-6891
CG Life
lstredler@cglife.com

FAQ

When is Asensus Surgical's participation in the H. C. Wainwright conference?

Asensus Surgical will participate in the H. C. Wainwright 24th Annual Global Investment Conference on September 12, 2022, at 9:30 AM ET.

Who will represent Asensus Surgical at the conference?

CEO Anthony Fernando and CFO Shameze Rampertab will represent Asensus Surgical at the conference.

How can I watch the Asensus Surgical conference webcast?

The webcast will be available live and on replay on the investor relations page of Asensus Surgical's website.

What is the focus of Asensus Surgical's presentation at the conference?

The presentation will focus on Performance-Guided Surgery™ and Digital Laparoscopy technologies.

Where can I find more information about Asensus Surgical's technologies?

More information about Asensus Surgical's technologies can be found on their official website.